Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis

American Journal of Sports Medicine

Volumn 44, Issue 4, 2016, Pages 884-891

  Smith, Patrick A ^a  

^a University of Missouri   (United States)

Author keywords

autologous conditioned plasma; FDA; leukocyte poor platelet rich plasma; level 1; osteoarthritis; placebo; saline control; WOMAC

Indexed keywords

CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE RICH PLASMA; UNITED STATES;

DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PLATELET-RICH PLASMA; PROSPECTIVE STUDIES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84962162097     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546515624678     Document Type: Article

References (50)

1. Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE,. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015; 162 (1): 46-54.
2. Bernad-Pineda M, de Las Heras-Sotos J, Garces-Puentes MV,. [Quality of life in patients with knee and hip osteoarthritis]. Rev Esp Cir Ortop Traumatol. 2014; 58 (5): 283-289.
3. Bodick N, Lufkin J, Willwerth C, et al. An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial. J Bone Joint Surg Am. 2015; 97 (11): 877-888.
4. Campbell KA, Erickson BJ, Saltzman BM, et al. Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: a systematic review of overlapping meta-analyses. Arthroscopy. 2015; 31 (10): 2036-2045.e14.
5. Cerza F, Carni S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012; 40 (12): 2822-2827.
6. Cole BJ, Fortier LA, Karas V, et al. HA vs. PRP: double-blind RCT comparing clinical outcomes and intra-articular biology for knee arthritis treatment. Poster presented at the AAOS Annual Meeting; March 24-28, 2015; Las Vegas, NV. http://aaos2015.conferencespot.org/58906-aaos-1.1965581/t002-1.1973805/f002-1.1973806/a020-1.1973978/p408-1.1974113.
7. Cole BJ, Schumacher HR Jr., Injectable corticosteroids in modern practice. J Am Acad Orthop Surg. 2005; 13 (1): 37-46.
8. Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA,. Platelet-rich plasma: where are we now and where are we going? Sports Health. 2010; 2 (3): 203-210.
9. Colen S, van den Bekerom MP, Mulier M, Haverkamp D,. Hyaluronic acid in the treatment of knee osteoarthritis: a systematic review and meta-analysis with emphasis on the efficacy of different products. BioDrugs. 2012; 26 (4): 257-268.
10. Creamer P,. Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 1999; 11 (5): 417-421.
11. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014; 73 (7): 1323-1330.
12. Faul F, Erdfelder E, Lang AG, Buchner A,. G∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007; 39 (2): 175-191.
13. Felson DT,. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev. 1988; 10: 1-28.
14. Filardo G, Di Matteo B, Di Martino A, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med. 2015; 43 (7): 1575-1582.
15. Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012; 20 (10): 2082-2091.
16. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA,. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009; 37 (11): 2259-2272.
17. Fransen M, McConnell S,. Land-based exercise for osteoarthritis of the knee: a metaanalysis of randomized controlled trials. J Rheumatol. 2009; 36 (6): 1109-1117.
18. Fransen M, McConnell S, Hernandez-Molina G, Reichenbach S,. Exercise for osteoarthritis of the hip. Cochrane Database Syst Rev. 2009;(3): CD007912.
19. Gallagher B, Tjoumakaris FP, Harwood MI, Good RP, Ciccotti MG, Freedman KB,. Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. Am J Sports Med. 2015; 43 (3): 734-744.
20. Gray RG, Gottlieb NL,. Intra-articular corticosteroids: an updated assessment. Clin Orthop Relat Res. 1983; 177: 235-263.
21. Hart R, Safi A, Komzak M, Jajtner P, Puskeiler M, Hartova P,. Platelet-rich plasma in patients with tibiofemoral cartilage degeneration. Arch Orthop Trauma Surg. 2013; 133 (9): 1295-1301.
22. Jackson DW, Evans NA, Thomas BM,. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am. 2002; 84 (9): 1522-1527.
23. Jamtvedt G, Dahm KT, Christie A, et al. Physical therapy interventions for patients with osteoarthritis of the knee: an overview of systematic reviews. Phys Ther. 2008; 88 (1): 123-136.
24. Johnson VL, Hunter DJ,. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol. 2014; 28 (1): 5-15.
25. Karlsson J, Sjogren LS, Lohmander LS,. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis: a controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford). 2002; 41 (11): 1240-1248.
26. Kellgren JH, Lawrence J,. The epidemiology of chronic rheumatism. In: Atlas of Standard Radiographs of Arthritis, Volume II. Oxford, UK: Blackwell Scientific; 1963.
27. Kon E, Buda R, Filardo G, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010; 18 (4): 472-479.
28. Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011; 27 (11): 1490-1501.
29. Lubowitz JH,. Editorial commentary: autologous platelet-rich plasma. Arthroscopy. 2015; 31 (4): 784.
30. Meheux CJ, McCulloch PC, Lintner DM, Varner KE, Harris JD,. Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review [published online September 29, 2015]. Arthroscopy. doi: 10.1016/j.arthro.2015.08.005.
31. Migliore A, Procopio S,. Effectiveness and utility of hyaluronic acid in osteoarthritis. Clin Cases Miner Bone Metab. 2015; 12 (1): 31-33.
32. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A,. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013; 41 (2): 356-364.
33. Raeissadat SA, Rayegani SM, Babaee M, Ghorbani E,. The effect of platelet-rich plasma on pain, function, and quality of life of patients with knee osteoarthritis. Pain Res Treat. 2013; 2013: 165967.
34. Rayegani SM, Raeissadat SA, Taheri MS, et al. Does intra articular platelet rich plasma injection improve function, pain and quality of life in patients with osteoarthritis of the knee? A randomized clinical trial. Orthop Rev (Pavia). 2014; 6 (3): 5405.
35. Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole BJ,. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis [published online April 29, 2015]. Am J Sports Med. pii:0363546515580787.
36. Ringdahl E, Pandit S,. Treatment of knee osteoarthritis. Am Fam Physician. 2011; 83 (11): 1287-1292.
37. Rock G, Tittley P, Fuller V,. Effect of citrate anticoagulants on factor VIII levels in plasma. Transfusion. 1988; 28 (3): 248-252.
38. Rozental TD, Sculco TP,. Intra-articular corticosteroids: an updated overview. Am J Orthop (Belle Mead NJ). 2000; 29 (1): 18-23.
39. Sánchez M, Anitua E, Azofra J, Aguirre JJ, Andia I,. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol. 2008; 26 (5): 910-913.
40. Sánchez M, Delgado D, Sánchez P, et al. Platelet rich plasma and knee surgery. Biomed Res Int. 2014; 2014: 890630.
41. Sánchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012; 28 (8): 1070-1078.
42. Say F, Gurler D, Yener K, Bulbul M, Malkoc M,. Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chir Orthop Traumatol Cech. 2013; 80 (4): 278-283.
43. Scarpignato C, Lanas A, Blandizzi C, et al. Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis-an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Med. 2015; 13: 55.
44. Silva LE, Valim V, Pessanha AP, et al. Hydrotherapy versus conventional land-based exercise for the management of patients with osteoarthritis of the knee: a randomized clinical trial. Phys Ther. 2008; 88 (1): 12-21.
45. Spakova T, Rosocha J, Lacko M, Harvanova D, Gharaibeh A,. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012; 91 (5): 411-417.
46. Sundman EA, Cole BJ, Fortier LA,. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011; 39 (10): 2135-2140.
47. Trigkilidas D, Anand A,. The effectiveness of hyaluronic acid intra-articular injections in managing osteoarthritic knee pain. Ann R Coll Surg Engl. 2013; 95 (8): 545-551.
48. US Food and Drug Administration. Summary of Safety and Effectiveness-SUPARTZ (P980044). Arlington, VA: Quintiles, Incorporated; 2001.
49. Vaquerizo V, Plasencia MA, Arribas I, et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy. 2013; 29 (10): 1635-1643.
50. Zhang Y, Jordan JM,. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010; 26 (3): 355-369.